Journal of Medical Physics
ORIGINAL ARTICLE
Year
: 2012  |  Volume : 37  |  Issue : 2  |  Page : 90--96

Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens


H Sudahar1, P. G. G. Kurup1, V Murali1, P Mahadev1, J Velmurugan2 
1 Department of Radiotherapy, Apollo Speciality Hospital, Chennai, India
2 Department of Medical Physics, Anna University, Chennai, India

Correspondence Address:
H Sudahar
Apollo Speciality Hospital, Department of Radiotherapy, 320, Padma Complex, Mount Road, Chennai - 600 035
India

As the α/β value of prostate is very small and lower than the surrounding critical organs, hypofractionated radiotherapy became a vital mode of treatment of prostate cancer. Cyberknife (Accuray Inc., Sunnyvale, CA, USA) treatment for localized prostate cancer is performed in hypofractionated dose regimen alone. Effective dose escalation in the hypofractionated regimen can be estimated if the corresponding conventional 2 Gy per fraction equivalent normalized total dose (NTD) distribution is known. The present study aims to analyze the hypofractionated dose distribution of localized prostate cancer in terms of equivalent NTD. Randomly selected 12 localized prostate cases treated in cyberknife with a dose regimen of 36.25 Gy in 5 fractions were considered. The 2 Gy per fraction equivalent NTDs were calculated using the formula derived from the linear quadratic (LQ) model. Dose distributions were analyzed with the corresponding NTDs. The conformity index for the prescribed target dose of 36.25 Gy equivalent to the NTD dose of 90.63 Gy (α/β = 1.5) or 74.31 Gy (α/β = 3) was ranging between 1.15 and 1.73 with a mean value of 1.32 ± 0.15. The D5% of the target was 111.41 ± 8.66 Gy for α/β = 1.5 and 90.15 ± 6.57 Gy for α/β = 3. Similarly, the D95% was 91.98 ± 3.77 Gy for α/β = 1.5 and 75.35 ± 2.88 Gy for α/β = 3. The mean values of bladder and rectal volume receiving the prescribed dose of 36.25 Gy were 0.83 cm3 and 0.086 cm3, respectively. NTD dose analysis shows an escalated dose distribution within the target for low α/β (1.5 Gy) with reasonable sparing of organs at risk. However, the higher α/β of prostate (3 Gy) is not encouraging the fact of dose escalation in cyberknife hypofractionated dose regimen of localized prostate cancer.


How to cite this article:
Sudahar H, Kurup P, Murali V, Mahadev P, Velmurugan J. Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens.J Med Phys 2012;37:90-96


How to cite this URL:
Sudahar H, Kurup P, Murali V, Mahadev P, Velmurugan J. Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens. J Med Phys [serial online] 2012 [cited 2020 Oct 27 ];37:90-96
Available from: https://www.jmp.org.in/article.asp?issn=0971-6203;year=2012;volume=37;issue=2;spage=90;epage=96;aulast=Sudahar;type=0